Larvol Delta - Preclinical-and-clinical-efficacy-of-the-HDAC6-inhibitor-ricolinostat-in-combination-with-BCR-pathway-inhibitors-in-relapsedrefractory-chronic-lymphocytic-leukemia

rocilinostat (ACY-1215) - Regenacy

https://www.nature.com/articles/s41408-026-01559-y

Jul 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next